These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 29309533)

  • 1. Exploring immune checkpoints as potential therapeutic targets in atherosclerosis.
    Kusters PJH; Lutgens E; Seijkens TTP
    Cardiovasc Res; 2018 Mar; 114(3):368-377. PubMed ID: 29309533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2016 Jeffrey M. Hoeg Award Lecture.
    Rouwet E; Lutgens E
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1678-1688. PubMed ID: 29930003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherosclerosis and immunity: A perspective.
    Abdolmaleki F; Gheibi Hayat SM; Bianconi V; Johnston TP; Sahebkar A
    Trends Cardiovasc Med; 2019 Aug; 29(6):363-371. PubMed ID: 30292470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in therapeutic targeting of inflammation in atherosclerosis.
    Hedin U; Matic LP
    J Vasc Surg; 2019 Mar; 69(3):944-951. PubMed ID: 30591299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation and atherosclerosis: what is on the horizon?
    Ruparelia N; Choudhury R
    Heart; 2020 Jan; 106(1):80-85. PubMed ID: 31843811
    [No Abstract]   [Full Text] [Related]  

  • 6. Atherosclerosis and autoimmunity: a growing relationship.
    Sanjadi M; Rezvanie Sichanie Z; Totonchi H; Karami J; Rezaei R; Aslani S
    Int J Rheum Dis; 2018 May; 21(5):908-921. PubMed ID: 29671956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel anti-inflammatory therapies for the treatment of atherosclerosis.
    Khan R; Spagnoli V; Tardif JC; L'Allier PL
    Atherosclerosis; 2015 Jun; 240(2):497-509. PubMed ID: 25917947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the immune response in atherosclerosis: It's time for clinical trials!
    Joffre J; Ait-Oufella H
    Arch Cardiovasc Dis; 2017 Dec; 110(12):643-645. PubMed ID: 29051009
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunotherapy for the prevention of atherosclerotic cardiovascular disease: Promise and possibilities.
    Khambhati J; Engels M; Allard-Ratick M; Sandesara PB; Quyyumi AA; Sperling L
    Atherosclerosis; 2018 Sep; 276():1-9. PubMed ID: 30006321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Utility of Anti-Inflammatory Agents in Cardiovascular Disease: A Novel Perspective on the Treatment of Atherosclerosis.
    Kottoor SJ; Arora RR
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):483-493. PubMed ID: 29783850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherosclerosis is a major human killer and non-resolving inflammation is a prime suspect.
    Fredman G; MacNamara KC
    Cardiovasc Res; 2021 Nov; 117(13):2563-2574. PubMed ID: 34609505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial: update on inflammatory targets modulating atherogenesis.
    Carbone F; Mach F; Montecucco F
    Curr Drug Targets; 2015; 16(4):282-3. PubMed ID: 25859799
    [No Abstract]   [Full Text] [Related]  

  • 13. The pleiotropic role of interleukin-17 in atherosclerosis.
    Allam G; Abdel-Moneim A; Gaber AM
    Biomed Pharmacother; 2018 Oct; 106():1412-1418. PubMed ID: 30119214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions.
    Raggi P; Genest J; Giles JT; Rayner KJ; Dwivedi G; Beanlands RS; Gupta M
    Atherosclerosis; 2018 Sep; 276():98-108. PubMed ID: 30055326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophages and dendritic cells: the usual suspects in atherogenesis.
    Kassiteridi C; Monaco C
    Curr Drug Targets; 2015; 16(4):373-82. PubMed ID: 25808566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional diversity of macrophages in vascular biology and disease.
    Park I; Kassiteridi C; Monaco C
    Vascul Pharmacol; 2017 Dec; 99():13-22. PubMed ID: 29074468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutraceutical therapies for atherosclerosis.
    Moss JW; Ramji DP
    Nat Rev Cardiol; 2016 Sep; 13(9):513-32. PubMed ID: 27383080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokines and Immune Responses in Murine Atherosclerosis.
    Kusters PJ; Lutgens E
    Methods Mol Biol; 2015; 1339():17-40. PubMed ID: 26445779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of pyroptosis in atherosclerosis and its therapeutic implications.
    He B; Nie Q; Wang F; Han Y; Yang B; Sun M; Fan X; Ye Z; Liu P; Wen J
    J Cell Physiol; 2021 Oct; 236(10):7159-7175. PubMed ID: 33755211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation.
    Martínez GJ; Celermajer DS; Patel S
    Atherosclerosis; 2018 Feb; 269():262-271. PubMed ID: 29352570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.